Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata impacts mental well-being more due to perceptions and stigma than disease severity.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

A comprehensive scoring system for alopecia areata severity is needed.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Alopecia areata after COVID-19 vaccination is rare but important to recognize for timely treatment.

COVID-19 increases the risk of hair loss, but vaccination can reduce this risk.

Neurogenic inflammation may play a role in hair loss in alopecia areata.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

Secukinumab for psoriasis may cause hair loss.

Certain blood markers, especially MLR, can help diagnose alopecia areata.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Machine learning can accurately identify Alopecia Areata, aiding in early detection and treatment of this hair loss condition.

Alopecia Areata causes significant structural and compositional changes in hair.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Using a nonablative fractional laser with topical minoxidil can effectively and safely promote hair regrowth in alopecia areata patients.

Ischemic modified albumin could be a new indicator of oxidative stress in people with alopecia areata.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

The girl's regrown brown hair had less of certain pigments than her original black hair.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

New, safer treatments for children's hair disorders are needed, and better evaluation methods are recommended.

Certain gene variations increase the risk of alopecia areata in Koreans.

Patients with alopecia areata should be checked for muscle spasms, diarrhea, and ANA to avoid missing Satoyoshi syndrome.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Mouse models help understand alopecia areata and find treatments.